Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Sellers Declined Their Shorts By 10.75%

June 27, 2018 - By Sarah Harris

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Corporate Logo

It was showed a decrease on Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s short interest with 10.75%. In June was issued TNXP’s total 196,800 short interest by FINRA. That’s 10.75% down from 220,500 shares. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has 55,800 shares average volume. It’ll cost 4 days for TNXP to restore its previous position. Float short on Tonix Pharmaceuticals Holding Corp is 3.09%.

TNXP reached $4.61 during the last trading session after $0.14 change.Tonix Pharmaceuticals Holding Corp. is downtrending after having declined 28.97% since June 27, 2017. TNXP has 120,187 volume or 4.97% up from normal. TNXP underperformed the S&P 500 by 41.54%.

Tonix Pharmaceuticals Holding Corp. engages in developing pharmaceutical and biological products to address public health challenges.The firm is worth $39.00 million. The Company’s lead product candidate, TNX-102 SL or Tonmya, designed as a bedtime treatment for posttraumatic stress disorder , which is in Phase 3 study in the military-related PTSD population.Last it reported negative earnings. The firm is also developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (investigational new drug) application stage, designed as a daytime treatment for posttraumatic stress disorder (PTSD); and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage.

For more Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) news posted recently go to: Benzinga.com, Benzinga.com, Seekingalpha.com, Globenewswire.com or Nasdaq.com. The titles are as follows: “40 Biggest Movers From Yesterday” posted on June 07, 2018, “40 Biggest Movers From Friday” on June 18, 2018, “Premarket analyst action – healthcare” with a publish date: June 06, 2018, “Tonix Pharmaceuticals to Present at the 2018 BIO International Convention” and the last “Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from …” with publication date: May 31, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.